You have my word that we will do our best to make sure that this kind of tragedy will never, never happen again.

The system failed and people died, and it could have been prevented.

A culture that allowed safety problems to fester for years will be hard to change, but if GM is going to recover and regain the public's trust, it has to learn from this report and break the patterns that led to this unimaginable…

we need to show the American public that the changes that have been announced will really address the longstanding problems at GM.

I find it very disturbing and downright devastating to you, to GM, to folks in Michigan who live and breathe pride in the auto industry, but most of all to the families of the victims.

the jury is still out on whether we can have success in changing the culture.

This latest recall raises even more questions about just how pervasive safety problems are at GM.

We launched the 21st Century Cures initiative with the goal of accelerating the discovery, development, and delivery of innovative new treatments and cures to patients, ensuring that the United States remains the biomedical innovation…

We did launch the 21st Century Cures Initiative with the goal of accelerating the discovery, development, and delivery of innovative new treatments and cures to patients, ensuring that the United States remains the biomedical innovation…

It is clear that our work is far from over. We lack effective treatments for almost 95 percent of the known diseases affecting patients today and over 95 percent of drugs in development do not make it to market.

We have got to heed the advice of the President's Council of Advisors and take a fresh look at current and potential economic incentives to promote innovation.

I'd like to commend Chairman Terry for his continued work on addressing the growing problem of patent trolls and their practice of sending deceptive demand letters, extorting thousands of dollars out of small businesses.

The President's advisors found that the Nation's biomedical innovation ecosystem is under significant stress.

The Internet has flourished under the current light-touch regulatory scheme, and subjecting it to burdensome regulations is a leap in the wrong direction.

Regardless of political affiliation, commissioners must be given adequate and equal time to consider the items on which they are going to vote.

The President, in soliciting recommendations on this important topic, decided propelling drug innovation is a policy worthy of exploring and advancing.

The Internet has indeed flourished under the current light-touch regulatory scheme, and subjecting it to burdensome regulations is a leap in the wrong direction.

I am troubled by the chairman's insistence on attempting to regulate the Internet under rules that were informed by 19th century railroad regulations.

Double the current annual output of innovative new medicines for patients with important unmet medical needs.

I have serious concerns with some others.

Oversight is a critical part of this committee's work to foster a smaller, more nimble government for the innovation age.

These actions, in the absence of the statutorily required media ownership review, do raise significant questions about the Commission's commitment to making decisions informed by facts and utilizing sound process.

I have serious concerns with others.

Today marks our first 21st Century Cures hearing at the Health Subcommittee.

The facts are the facts, and while the administration and its allies furiously try to muddy reality, the public deserves transparency.